91ÉçÇø

91ÉçÇø.ca / Overview / Faculty of Medicine / Graduate / Programs

Master of Science (M.Sc.); Pharmacology (Thesis) (45 credits)

Note: This is the 2011–2012 edition of the eCalendar. Update the year in your browser's URL bar for the most recent version of this page, or click here to jump to the newest eCalendar.

Offered by: Pharmacology and Therapeutics     Degree: Master of Science

Program Requirements

Thesis Courses (24 credits)

Required Courses (9 credits)

Complementary Courses (12 credits)

6 credits, from the following courses:

  • PHAR 562 General Pharmacology 1 (3 credits)

    Offered by: Pharmacology and Therapeutics (Faculty of Science)

    Overview

    Pharmacology and Therapeutics : Topics in pharmacology with an emphasis on molecular aspects and the nervous system; topics include molecular mechanisms of drug-action, cellular targets and rationale for therapeutics.

    Terms: Fall 2011

    Instructors: Almazan, Guillermina (Fall)

    • Fall

    • Prerequisite: PHAR 301.

    • Restriction: Open to U3 students in the minor, major or honours program in Pharmacology, or with permission of instructor.

  • PHAR 563 General Pharmacology 2 (3 credits)

    Offered by: Pharmacology and Therapeutics (Faculty of Science)

    Overview

    Pharmacology and Therapeutics : Selected topics in pharmacology of the endocrine, metabolic, and cardiovascular systems. Additional topics include: pharmacogenetics/pharmacogenomics, chronopharmacology, molecular structure in pharmacology, epigenetic targets in cancer chemotherapy, and stem cell therapies.

    Terms: Winter 2012

    Instructors: Bernard, Daniel (Winter)

    • Winter

    • Prerequisite: PHAR 301.

    • Restriction: Open to U3 students in the minor, major or honours program in Pharmacology, or with permission of instructor.

or, for students who have taken PHAR 562 and PHAR 563 as part of their undergraduate degree, they will register for the following course:

6 credits, two 700-level PHAR courses.

Faculty of Medicine—2011-2012 (last updated Aug. 18, 2011) (disclaimer)
Back to top